VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe

21/10/2024
22/06/2026
EU PAS number:
EUPAS1000000337
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol_PAES_6578_HIPRA_BIMERVAX_v1.1_19Feb2024_Redacted.pdf

English (1.71 MB - PDF) View document
Updated protocol

Protocol_PAES_6578_HIPRA_BIMERVAX_v3.0_Final_31Oct2025_Redacted.pdf

First published: 12/02/2026
English (1.04 MB - PDF) View document

Protocol_PAES_6578_HIPRA_BIMERVAX_v2.0_12March2025_redacted.pdf

First published: 25/11/2025
English (1.01 MB - PDF) View document
Study results
Study report
Other information
Study, other information

Bimervax Effectiveness_DeclarationofInterests-Annex5 VAC4EU Daniel Weibel.pdf

English (104.89 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_A Girardi.pdf

English (105.31 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_AGM.pdf

English (105.01 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_Arantxa Urchueguía.pdf

English (130.26 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_ASM_signed_ASM.pdf

English (179.86 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_BPP.pdf

English (104.73 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_CR.pdf

English (104.54 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_Davide_Messina.pdf

English (105.09 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_DM.pdf

English (189.6 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_ECM.pdf

English (132.52 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_EP.pdf

English (186.61 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_EVC.pdf

English (104.88 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_FV.pdf

English (105.32 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_G Roberto.pdf

English (105.62 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_GS.pdf

English (104.99 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_JBL.pdf

English (222.59 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_JD.pdf

English (106.52 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_JJCM.pdf

English (130.7 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_JMSG.pdf

English (105.73 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_JR.pdf

English (92.91 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_JVG.pdf

English (105.9 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_KB.pdf

English (105.41 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_LG.pdf

English (106.01 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_M Soriano Gabarro 27 Jan 2026.pdf

English (105.02 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_MFR.pdf

English (138.79 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_Miller.pdf

English (104.93 KB - PDF) View document

Bimervax Effectiveness_Declarationofinterests-Annex5_MS.pdf

English (4.13 MB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_PAB.pdf

English (105.57 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_Paoletti.pdf

English (105.41 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_R Gini.pdf

English (106.7 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_SB.pdf

English (105.45 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_SPG.pdf

English (106.51 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_SR.pdf

English (105.47 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_VR.pdf

English (117.91 KB - PDF) View document

Bimervax Effectiveness_DeclarationofInterests-Annex5_XGA.pdf

English (106.81 KB - PDF) View document
ENCePP Seal
Conflicts of interest of investigators

01_DeclarationofInterests-Annex5 - signed.pdf

English (222.59 KB - PDF) View document
Composition of steering group and observers

02_ENCePPCoCSteeringGroup.pdf

English (43.37 KB - PDF) View document
Signed code of conduct

03_ENCePPCoCAnnex3_DeclarationofcompliancewiththeENCePPCodeofConduct - signed.pdf

English (161.23 KB - PDF) View document
Signed code of conduct checklist

04_ENCePPCoCAnnex2_ChecklistofCodeofConduct - signed.pdf

English (307.26 KB - PDF) View document
Signed checklist for study protocols

05_ENCePPChecklistforStudyProtocol - signed.pdf

English (515.48 KB - PDF) View document